Reduced survival of apolipoprotein E4 homozygotes in Down's syndrome?

NeuroReport

Volumn 7, Issue 15-17, 1996, Pages 2455-2456

  Holder, J L ^a   Habbak, R A ^a   Pearlson, G D ^b   Aylward, E A ^b   Pulsifer, M ^b   Warren, A C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

ApoE; Down's syndrome

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029827790     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199611040-00010     Document Type: Article

References (12)

1. Malamud N. Adv Behav Biol 3, 63-87 (1973).
2. Saunder AM, Strittmatter WJ, Schmechel D et al. Neurology 43, 1467-1472 (1993).
3. Corder EH, Saunders AM, Strittmatter WJ et al. Science 261, 921-923 (1993).
4. Corder EH, Saunders AM, Risch NJ et al. Nat Genet 7, 180-184 (1994).
5. Schachter F, Faure-Delanef L, Guenot F et al. Nat Genet 6, 29-32 (1994).
6. Van Gool WA, Evenhuis HM, and van Duijin CM. Ann Neurol 38, 225-230 (1995).
7. Wenham PR, Price WH and Blandell G. Lancet 337, 1158-1159 (1991).
8. Royston MC, Mann D, Pickering-Brown S et al. NeuroReport 5, 2583-2585 (1995).
9. Hardy J, Crook R, Perry R et al. Lancet 343, 979-980 (1994).
10. Wisniewski T, Morelli L, Wegiel J et al. Ann Neurol 37, 136-138 (1995).
11. Van Bockxmeer FM and Mamotte CDS. Lancet 340, 879-880 (1992).
12. Avramopoulos D, Mikkelsen M, Vassilopoulos D et al. Lancet 347, 862-865 (1996).